Revenue
2018
2019
2020
2021
2022
2023
2024
2025
TALPHERA, INC. (TLPH)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2018
2019
2020
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $28,000 | $0 | $651,000 | $0 | $2.8M | $5.4M | $2.3M | $2.2M | $8.0M | $17.4M | $19.3M | $5.2M | $29.5M | $2.4M | $1.1M | — | — | — | — | — |
| Research & development | $6.0M | $6.7M | $5.5M | $3.3M | $4.1M | $4.0M | $4.7M | $13.1M | $19.4M | $21.4M | $22.5M | $24.5M | $26.3M | $24.9M | $13.6M | $8.2M | $15.5M | — | — | — |
| Operating expenses | — | — | — | — | — | — | — | $37.9M | $46.7M | $49.3M | $39.2M | $42.9M | $36.2M | $32.1M | $20.4M | $12.2M | $19.0M | — | — | — |
| Operating income | −$13.5M | −$15.3M | −$16.9M | −$25.3M | −$36.0M | −$41.0M | −$54.2M | −$35.7M | −$38.7M | −$32.0M | −$20.0M | −$37.6M | −$6.7M | — | — | — | — | — | — | — |
| EBITDAderived | — | −$15.3M | −$16.6M | −$23.7M | −$34.0M | −$39.1M | −$52.5M | −$35.2M | −$36.9M | −$29.9M | −$18.0M | −$36.8M | −$6.1M | — | — | — | — | — | — | — |
| Net income | −$14.3M | −$13.0M | −$18.4M | $47.8M | −$35.1M | −$40.4M | −$53.2M | −$47.1M | −$51.5M | −$43.2M | −$24.4M | −$33.4M | −$23.4M | −$33.4M | −$20.1M | −$14.3M | −$20.1M | −$20.7M | −$9.6M | −$3.8M |
| Basic EPSper diluted share | -$0.34 | -$0.50 | -$1.29 | $5.73 | -$5.86 | -$0.47 | -$0.67 | -$0.81 | -$1.10 | -$0.95 | -$0.55 | -$0.77 | -$0.59 | -$1.51 | -$1.16 | -$21.84 | -$34.93 | — | — | — |
| Diluted EPSper diluted share | — | — | -$1.29 | $5.72 | -$5.86 | -$0.47 | -$0.67 | -$0.81 | -$1.10 | -$0.95 | -$0.60 | -$0.91 | -$0.59 | -$1.51 | -$1.16 | -$21.84 | -$34.93 | — | — | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 13, 2026Form 4 | Angotti Vincent J.CHIEF EXECUTIVE OFFICER | BuyCommon Stock | 213.3K | $0.59 | $125.9K | 800.7K |
| Feb 12, 2026Form 4 | Aslam ShakilChief Medical Officer | BuyCommon Stock | 35.0K | $0.81 | $28.4K | 83.2K |
| Feb 12, 2026Form 4 | Angotti Vincent J.CHIEF EXECUTIVE OFFICER | BuyCommon Stock | 105.4K | $0.81 | $85.3K | 587.0K |
| Feb 12, 2026Form 4 | ASADORIAN RAFFIChief Financial Officer | BuyCommom Stock | 45.0K | $0.81 | $36.5K | 91.3K |
| Feb 12, 2026Form 4 | Dasu Badri NChief Engineering Officer | BuyCommon Stock | 35.0K | $0.81 | $28.4K | 76.2K |